Literature DB >> 22993319

Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells.

Shuang Wu1, Tatsuo Kanda, Shingo Nakamoto, Fumio Imazeki, Osamu Yokosuka.   

Abstract

BACKGROUND: Receptor-interacting serine/threonine protein kinase-2 (RIPK2) has been reported to be an important regulator of tumor proliferation, differentiation and wound repair. We investigated the effects of RIPK2 knockdown in human hepatoma cells on epithelial-to-mesenchymal transition (EMT)-associated gene expression.
MATERIALS AND METHODS: HepG2 cells stably expressing RIPK2-shRNA (HepG2-shRIPK2) were generated after puromycin selection. Total RNAs from HepG2-shRIPK2 and from HepG2-shcontrol cells were isolated and PCR-based arrays were performed to compare the 84 EMT-associated gene expressions.
RESULTS: We observed that knockdown of RIPK2 down-regulated mRNA expression of jagged 1 (JAG1); plasminogen activator inhibitor-1 (PAI1); regulator of G-protein signalling 2, 24 kDa (RGS2); E-cadherin (CDH1); fibroblast growth factor binding protein 1 (FGFBP1); snail homolog 2 (SNAI2); protein tyrosine phosphatase type IVA, member 1 (PTP4A1); keratin 19 (KRT19); vimentin (VIM); and survival of motor neuron protein-interacting protein 1 (SIP1).
CONCLUSION: We found that knockdown of RIPK2 down-regulated nuclear factor kappa B (NF-κB)-dependent PAI1 and VIM gene expressions. RIPK2 might play an important role in hepatic cell migration. These findings could shed new light on carcinogenesis and on liver regeneration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22993319

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification.

Authors:  Christopher M Browne; Baishan Jiang; Scott B Ficarro; Zainab M Doctor; Jared L Johnson; Joseph D Card; Sindhu Carmen Sivakumaren; William M Alexander; Tomer M Yaron; Charles J Murphy; Nicholas P Kwiatkowski; Tinghu Zhang; Lewis C Cantley; Nathanael S Gray; Jarrod A Marto
Journal:  J Am Chem Soc       Date:  2018-12-20       Impact factor: 15.419

2.  NEO212 Inhibits Migration and Invasion of Glioma Stem Cells.

Authors:  Nagore I Marín-Ramos; Thu Zan Thein; Hee-Yeon Cho; Stephen D Swenson; Weijun Wang; Axel H Schönthal; Thomas C Chen; Florence M Hofman
Journal:  Mol Cancer Ther       Date:  2018-02-13       Impact factor: 6.261

3.  Gene expression profiling of RIP2-knockdown in HD11 macrophages - elucidation of potential pathways (gene network) when challenged with avian pathogenic E.coli (APEC).

Authors:  Hongyan Sun; Yexin Yang; Yuxuan Cao; Huan Li; Lujiang Qu; Susan J Lamont
Journal:  BMC Genomics       Date:  2022-05-02       Impact factor: 4.547

4.  Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.

Authors:  Asaf Madi; Sharron Bransburg-Zabary; Ayala Maayan-Metzger; Gittit Dar; Eshel Ben-Jacob; Irun R Cohen
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

5.  Knockdown of RIPK2 Inhibits Proliferation and Migration, and Induces Apoptosis via the NF-κB Signaling Pathway in Gastric Cancer.

Authors:  Qian Yang; Shan Tian; Zhengru Liu; Weiguo Dong
Journal:  Front Genet       Date:  2021-02-09       Impact factor: 4.599

6.  A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours.

Authors:  Hanqun Zhang; Yan Ma; Qiuning Zhang; Ruifeng Liu; Hongtao Luo; Xiaohu Wang
Journal:  BMC Med Genomics       Date:  2022-04-26       Impact factor: 3.063

Review 7.  The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Brian J North; Kaixiong Tao; Pengbo Zhou; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

8.  Role of Rip2 in development of tumor-infiltrating MDSCs and bladder cancer metastasis.

Authors:  Hanwei Zhang; Arnold I Chin
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

9.  Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer.

Authors:  Rola F Jaafar; Zeid Ibrahim; Karim Ataya; Joelle Hassanieh; Natasha Ard; Walid Faraj
Journal:  Medicina (Kaunas)       Date:  2021-07-14       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.